105 related articles for article (PubMed ID: 10206303)
1. Expression of the thymidine phosphorylase gene in epithelial ovarian cancer.
Hata K; Kamikawa T; Arao S; Tashiro H; Katabuchi H; Okamura H; Fujiwaki R; Miyazaki K; Fukumoto M
Br J Cancer; 1999 Apr; 79(11-12):1848-54. PubMed ID: 10206303
[TBL] [Abstract][Full Text] [Related]
2. Expression of the Endostatin gene in epithelial ovarian cancer.
Hata K; Fujiwaki R; Nakayama K; Miyazaki K
Clin Cancer Res; 2001 Aug; 7(8):2405-9. PubMed ID: 11489819
[TBL] [Abstract][Full Text] [Related]
3. Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo.
Tsukagoshi S; Saga Y; Suzuki N; Fujioka A; Nakagawa F; Fukushima M; Suzuki M
Int J Oncol; 2003 May; 22(5):961-7. PubMed ID: 12684660
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of the RIalpha subunit of the cAMP-dependent protein kinase A is associated with advanced stage ovarian cancer.
McDaid HM; Cairns MT; Atkinson RJ; McAleer S; Harkin DP; Gilmore P; Johnston PG
Br J Cancer; 1999 Feb; 79(5-6):933-9. PubMed ID: 10070893
[TBL] [Abstract][Full Text] [Related]
5. Thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase expression, and histological tumour regression after 5-FU-based neo-adjuvant chemoradiotherapy in rectal cancer.
Jakob C; Aust DE; Meyer W; Baretton GB; Schwabe W; Häusler P; Becker H; Liersch T
J Pathol; 2004 Dec; 204(5):562-8. PubMed ID: 15538739
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of histologic tumor regression, thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase in rectal cancer UICC Stage II/III after neoadjuvant chemoradiotherapy.
Jakob C; Liersch T; Meyer W; Baretton GB; Schwabe W; Häusler P; Kulle B; Becker H; Aust DE
Am J Surg Pathol; 2006 Sep; 30(9):1169-74. PubMed ID: 16931962
[TBL] [Abstract][Full Text] [Related]
7. Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer.
Shigemasa K; Tian X; Gu L; Tanimoto H; Underwood LJ; O'Brien TJ; Ohama K
Oncol Rep; 2004 Jun; 11(6):1153-9. PubMed ID: 15138549
[TBL] [Abstract][Full Text] [Related]
8. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
[TBL] [Abstract][Full Text] [Related]
9. The angiogenic factor thymidine phosphorylase up-regulates the cell adhesion molecule P-selectin in human vascular endothelial cells and is associated with P-selectin expression in breast cancers.
Gunningham SP; Currie MJ; Morrin HR; Tan EY; Turley H; Dachs GU; Watson AI; Frampton C; Robinson BA; Fox SB
J Pathol; 2007 Jul; 212(3):335-44. PubMed ID: 17487938
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of numeric aberrations of genes for thymidylate synthase, thymidine phosphorylase and dihydrofolate reductase in colorectal cancer.
Jensen SA; Vainer B; Witton CJ; Jørgensen JT; Sørensen JB
Acta Oncol; 2008; 47(6):1054-61. PubMed ID: 18607850
[TBL] [Abstract][Full Text] [Related]
11. Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer.
Okumura K; Shiomi H; Mekata E; Kaizuka M; Endo Y; Kurumi Y; Tani T
Oncol Rep; 2006 Apr; 15(4):875-82. PubMed ID: 16525674
[TBL] [Abstract][Full Text] [Related]
12. The relationship of insulin-like growth factor-II, insulin-like growth factor binding protein-3, and estrogen receptor-alpha expression to disease progression in epithelial ovarian cancer.
Lu L; Katsaros D; Wiley A; Rigault de la Longrais IA; Risch HA; Puopolo M; Yu H
Clin Cancer Res; 2006 Feb; 12(4):1208-14. PubMed ID: 16489075
[TBL] [Abstract][Full Text] [Related]
13. Loss of DCC gene expression during ovarian tumorigenesis: relation to tumour differentiation and progression.
Saegusa M; Machida D; Okayasu I
Br J Cancer; 2000 Feb; 82(3):571-8. PubMed ID: 10682668
[TBL] [Abstract][Full Text] [Related]
14. Expression of metastin and a G-protein-coupled receptor (AXOR12) in epithelial ovarian cancer.
Hata K; Dhar DK; Watanabe Y; Nakai H; Hoshiai H
Eur J Cancer; 2007 Jun; 43(9):1452-9. PubMed ID: 17442564
[TBL] [Abstract][Full Text] [Related]
15. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological significance of circadian rhythm-related gene expression levels in patients with epithelial ovarian cancer.
Tokunaga H; Takebayashi Y; Utsunomiya H; Akahira J; Higashimoto M; Mashiko M; Ito K; Niikura H; Takenoshita S; Yaegashi N
Acta Obstet Gynecol Scand; 2008; 87(10):1060-70. PubMed ID: 18720043
[TBL] [Abstract][Full Text] [Related]
17. [Elevated expression of matrix metalloproteinase-9, and fibronectin concentration in recurrent epithelial ovarian cancer].
Demeter A; Szirmai K; Oláh J; Papp Z; Jeney A
Orv Hetil; 2004 Aug; 145(31):1617-24. PubMed ID: 15384859
[TBL] [Abstract][Full Text] [Related]
18. [Expression of thymidine phosphorylase in primary colorectal cancer and liver metastasis-relationship between mRNA levels in cancer cells and protein levels in cancerous tissue].
Ishibashi K; Sobajima J; Ishiguro T; Okada N; Miyazaki T; Yokoyama M; Ishida H
Gan To Kagaku Ryoho; 2009 Mar; 36(3):425-9. PubMed ID: 19295266
[TBL] [Abstract][Full Text] [Related]
19. Gene expression for dihydropyrimidine dehydrogenase and thymidine phosphorylase influences outcome in epithelial ovarian cancer.
Fujiwaki R; Hata K; Nakayama K; Fukumoto M; Miyazaki K
J Clin Oncol; 2000 Dec; 18(23):3946-51. PubMed ID: 11099324
[TBL] [Abstract][Full Text] [Related]
20. High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancer.
Sayer RA; Lancaster JM; Pittman J; Gray J; Whitaker R; Marks JR; Berchuck A
Gynecol Oncol; 2005 Feb; 96(2):355-61. PubMed ID: 15661221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
